Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Overexpression of human BAG3P209L in mice causes restrictive cardiomyopathy. Nature communications Kimura, K., Ooms, A., Graf-Riesen, K., Kuppusamy, M., Unger, A., Schuld, J., Daerr, J., Lother, A., Geisen, C., Hein, L., Takahashi, S., Li, G., Roll, W., Bloch, W., van der Ven, P. F., Linke, W. A., Wu, S. M., Huesgen, P. F., Hohfeld, J., Furst, D. O., Fleischmann, B. K., Hesse, M. 2021; 12 (1): 3575

Abstract

An amino acid exchange (P209L) in the HSPB8 binding site of the human co-chaperone BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice and gain insight into its mechanisms, we generated humanized transgenic mouse models. Expression of human BAG3P209L-eGFP in mice caused Z-disc disintegration and formation of protein aggregates. This was accompanied by massive fibrosis resulting in early-onset restrictive cardiomyopathy with increased mortality as observed in patients. RNA-Seq and proteomics revealed changes in the protein quality control system and increased autophagy in hearts from hBAG3P209L-eGFP mice. The mutation renders hBAG3P209L less soluble in vivo and induces protein aggregation, but does not abrogate hBAG3 binding properties. In conclusion, we report a mouse model mimicking the human disease. Our data suggest that the disease mechanism is due to accumulation of hBAG3P209L and mouse Bag3, causing sequestering of components of the protein quality control system and autophagy machinery leading to sarcomere disruption.

View details for DOI 10.1038/s41467-021-23858-7

View details for PubMedID 34117258